MARLEX PHARMACEUTICALS INC

Marlex Pharmaceuticals Inc. specializes in the manufacturing of active pharmaceutical ingredients and finished dosage forms, with deep expertise in tablet production for high-demand therapeutics. The company focuses on precision manufacturing of corticosteroids such as prednisone in multiple strengths (5 mg, 10 mg, 20 mg) and antitubercular agents like pyrazinamide, adhering to cGMP standards for consistency, stability, and bioavailability. Their technical capabilities include solid dosage form development, powder blending, compression, and quality control protocols compliant with USP and FDA requirements, serving mission-critical needs for military and veteran healthcare systems. Differentiators include rapid-scale production of high-volume, low-margin essential medicines with strict batch traceability and regulatory documentation integrity. The contractor maintains a consistent, long-term relationship with the Department of Defense, supplying essential medications for deployment readiness, field medical units, and institutional pharmacy inventories. Additionally, they support the Department of Veterans Affairs through the Federal Supply Schedule, providing bulk pharmaceuticals for VA medical centers and outpatient clinics, ensuring uninterrupted access to chronic disease management therapies. Marlex operates primarily under NAICS 325411 (Medicinal and Botanical Manufacturing), indicating active pharmaceutical ingredient synthesis and formulation, with secondary activity in 325412 (Pharmaceutical Preparation Manufacturing), reflecting finished product packaging and distribution. Their market positioning centers on the government’s need for reliable, domestically sourced generic drug supply chains, particularly for Tier-1 essential medicines with narrow therapeutic indices. As a 2L entity based in New Castle, Delaware, Marlex Pharmaceuticals Inc. is structured as a small business with no federal certifications on record. Their geographic footprint is concentrated in the Mid-Atlantic region, with operations tailored to meet federal procurement timelines and logistics requirements for defense and veteran health systems. The company’s presence reflects a strategic focus on sustaining critical pharmaceutical supply lines within the U.S. government’s secure procurement ecosystem.